» Articles » PMID: 18981305

Exercise-induced Pulmonary Arterial Hypertension

Overview
Journal Circulation
Date 2008 Nov 5
PMID 18981305
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The clinical relevance of exercise-induced pulmonary arterial hypertension (PAH) is uncertain, and its existence has never been well studied by direct measurements of central hemodynamics. Using invasive cardiopulmonary exercise testing, we hypothesized that exercise-induced PAH represents a symptomatic stage of PAH, physiologically intermediate between resting pulmonary arterial hypertension and normal.

Methods And Results: A total of 406 consecutive clinically indicated cardiopulmonary exercise tests with radial and pulmonary arterial catheters and radionuclide ventriculographic scanning were analyzed. The invasive hemodynamic phenotype of exercise-induced PAH (n=78) was compared with resting PAH (n=15) and normals (n=16). Log-log plots of mean pulmonary artery pressure versus oxygen uptake (V(.)o(2)) were obtained, and a "join-point" for a least residual sum of squares for 2 straight-line segments (slopes m1, m2) was determined; m2<m1="plateau," and m2>m1="takeoff" pattern. At maximum exercise, V(.)o(2) (55.8+/-20.3% versus 66.5+/-16.3% versus 91.7+/-13.7% predicted) was lowest in resting PAH, intermediate in exercise-induced PAH, and highest in normals, whereas mean pulmonary artery pressure (48.4+/-11.1 versus 36.6+/-5.7 versus 27.4+3.7 mm Hg) and pulmonary vascular resistance (294+/-158 versus 161+/-60 versus 62+/-20 dyne x s x cm(-5), respectively; P<0.05) followed an opposite pattern. An exercise-induced PAH plateau (n=32) was associated with lower o(2)max (60.6+/-15.1% versus 72.0+/-16.1% predicted) and maximum cardiac output (78.2+/-17.1% versus 87.8+/-18.3% predicted) and a higher resting pulmonary vascular resistance (247+/-101 versus 199+/-56 dyne x s x cm(-5); P<0.05) than takeoff (n=40). The plateau pattern was most common in resting PAH, and the takeoff pattern was present in nearly all normals.

Conclusions: Exercise-induced PAH is an early, mild, and clinically relevant phase of the PAH spectrum.

Citing Articles

Physical exercise for pulmonary arterial hypertension diagnosis and therapy.

Lwin M, Masding A, McCabe C Int J Cardiol Congenit Heart Dis. 2025; 19:100565.

PMID: 40066343 PMC: 11891737. DOI: 10.1016/j.ijcchd.2025.100565.


Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing.

Tarras E, Singh I, Kreiger J, Joseph P J Clin Med. 2025; 14(3).

PMID: 39941482 PMC: 11818252. DOI: 10.3390/jcm14030804.


Invasive Cardiopulmonary Exercise Testing in Chronic Thromboembolic Pulmonary Disease; Obesity and the V/VCO Relationship.

Oliveros E, Mauri M, Pietrowicz R, Sadek A, Lakhter V, Bashir R J Clin Med. 2025; 13(24.

PMID: 39768625 PMC: 11677292. DOI: 10.3390/jcm13247702.


Cardiopulmonary exercise testing in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Coulis A, Levanon S, Randhawa G, Brailovsky Y, Raza F, Oliveros E Front Sports Act Living. 2024; 6:1477562.

PMID: 39635043 PMC: 11614647. DOI: 10.3389/fspor.2024.1477562.


Vasoreactivity and inhaled treprostinil response in interstitial lung disease pulmonary hypertension.

Harder E, Rahaghi F, Leopold J, Systrom D, Washko G, Waxman A ERJ Open Res. 2024; 10(6).

PMID: 39624389 PMC: 11609945. DOI: 10.1183/23120541.00201-2024.


References
1.
James K, Maurer J, Wolski K, Lutton S, Haas G, Schilz R . Exercise hemodynamic findings in patients with exertional dyspnea. Tex Heart Inst J. 2000; 27(2):100-5. PMC: 101041. View

2.
Raeside D, Smith A, Brown A, Patel K, Madhok R, Cleland J . Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension. Eur Respir J. 2000; 16(2):282-7. DOI: 10.1034/j.1399-3003.2000.16b16.x. View

3.
Grunig E, Janssen B, Mereles D, Barth U, Borst M, Vogt I . Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation. 2000; 102(10):1145-50. DOI: 10.1161/01.cir.102.10.1145. View

4.
Kafi S, Melot C, Vachiery J, Brimioulle S, Naeije R . Partitioning of pulmonary vascular resistance in primary pulmonary hypertension. J Am Coll Cardiol. 1998; 31(6):1372-6. DOI: 10.1016/s0735-1097(98)00091-6. View

5.
Maroni J, Oelberg D, Pappagianopoulos P, Boucher C, Systrom D . Maximum cardiac output during incremental exercise by first-pass radionuclide ventriculography. Chest. 1998; 114(2):457-61. DOI: 10.1378/chest.114.2.457. View